SCHEMBL457251

SCHEMBL457251

CC(C)CC1CCOC(O)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18829872 0.88
SCHEMBL12166677 0.69
SCHEMBL4358910 0.69
SCHEMBL25477459 0.69
SCHEMBL12166507 0.68 PTGS1 (0.38)
SCHEMBL12166943 0.68
SCHEMBL7753145 0.66
SCHEMBL26138062 0.65
SCHEMBL1696604 0.65
SCHEMBL6333474 0.65 MEN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111671681-A Cosmetic composition, cosmetic and preparation method thereof 深圳市智为时代科技有限公司 2020-09-18 CN claimed
US-10682302-B2 Cosmetic compositions MARY KAY INC. (US) 2020-06-16 US claimed
US-20180161265-A1 COSMETIC COMPOSITIONS MARY KAY INC. 2018-06-14 US claimed
US-20160303019-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. 2016-10-20 US claimed
US-9402794-B2 Topical skin care formulation MARY KAY INC. (US) 2016-08-02 US claimed
WO-2015066194-A1 COSMETIC COMPOSITIONS MARY KAY INC. (US) 2015-05-07 WO claimed
US-20150118176-A1 COSMETIC COMPOSITIONS MARY KAY INC. 2015-04-30 US claimed
US-8318222-B2 Topical skin care formulation MARY KAY, INC. (US) 2012-11-27 US claimed
US-20110206793-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. (US) 2011-08-25 US claimed
US-12605308-B2 Topical skin care formulations comprising plant extracts MARY KAY INC. (US) 2026-04-21 US disclosed
US-20260000603-A1 TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS MARY KAY INC. (US) 2026-01-01 US disclosed
EP-4592279-A2 MYELINATION STIMULATOR COMPOUNDS, AND METHODS OF TREATMENT University of Florida Research Foundation, Incorporated (US) 2025-07-30 EP disclosed
EP-3813824-B1 USE OF MYELINATION STIMULATOR COMPOUNDS UNIV FLORIDA (US) 2025-07-02 EP disclosed
US-12303586-B2 Topical skin care formulations comprising plant extracts MARY KAY INC. (US) 2025-05-20 US disclosed
WO-2003009819-A2 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS DOW CORNING CORPORATION (US) 2003-02-06 WO disclosed
US-6498197-B1 Temperature insensitive one-phase microemulsions DOW CORNING CORPORATION 2002-12-24 US disclosed
EP-1256336-A2 Two-phase gel composition Penreco (US) 2002-11-13 EP disclosed
US-20020055562-A1 Gel compositions WILMINGTON TRUST, NATIONAL ASSOCIATION 2002-05-09 US disclosed
EP-1141111-A1 GEL COMPOSITIONS Penreco (US) 2001-10-10 EP disclosed
WO-2000026285-A1 GEL COMPOSITIONS PENRECO (US) 2000-05-11 WO disclosed